Gemma Colomer Travé | Fieldfisher
Skip to main content
Professional background

Professional background

I am a senior associate in the Life Sciences practice and have more than fifteen years of experience advising companies in the pharmaceutical and healthcare sectors. I specialise in pharmaceutical law, particularly regulatory matters and compliance with sectoral codes of conduct and internal compliance policies applicable to the pharmaceutical and medical device industries. In this field, I have worked as an in-house consultant for companies in the sector, supporting the implementation of codes of conduct and internal procedures.

I also have experience in the contractual field, advising pharmaceutical and healthcare companies on the drafting and negotiation of all types of sector-specific agreements.

In addition, my previous experience in Fieldfisher’s Litigation practice has enabled me to manage litigation proceedings for pharmaceutical and healthcare companies before administrative authorities, ordinary courts and the bodies responsible for enforcing sectoral codes of conduct.

I am a regular contributor to various publications specialising in pharmaceutical law.

Authored pieces

All Resources
Close-up of a laboratory setup showing multiple pipettes dispensing liquid into a row of wells in a transparent microplate. A petri dish containing a pink liquid is visible in the background, both items resting on a lab bench. Bright, colorful lighting is used.
Insight

New Guidance on social media and digital channels approved by IFPMA and EFPIA

02.11.2022
On September 28, 2022, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) issued a Joint Note for Guidance on social media and digital channels.
Learn more
A close-up shot of a syringe with a sharp needle, filled with a red liquid, placed against a smooth gradient background of light blue and white. The syringe is slightly angled, with the needle pointing to the left.
Insight

EU v AstraZeneca: Lessons on contractual agreements for the life sciences industry

07.05.2021
Learn more
Insight

The new code of good practice of Farmaindustria for 2021

09.12.2020
Learn more
Insight

New Spanish Royal Decree on Observational Studies with medicinal products for human use

29.11.2020
Learn more
News

European Medicines Agency. Barcelona is ready (in Spanish)

08.09.2017
The article that follows is written in Spnaish: Comienza la recta final para seleccionar la nueva sede de la Agencia Europea del Medicamento. Toda agencia de la Unión Europea necesita un emplazamiento emblemático, y a la Agencia Europea del Medicamento (EMA, por sus siglas en inglés) no le faltan pretendientes. Desde su fundación en 1995, la EMA ha evaluado y supervisado los procedimientos de autorización centralizados y las remisiones a los sistemas nacionales de todos...
Learn more